Long-term persisting interferon beta-1b neutralizing antibodies after discontinuation of treatment
Author:
Publisher
Wiley
Subject
Neurology (clinical),Neurology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1600-0404.2003.00180.x/fullpdf
Reference19 articles.
1. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis;Jacobs;Ann Neurol,1996
2. Randomized, double-blind, placebo-controlled study of interferon-beta 1a in relapsing-remitting multiple sclerosis: clinical results;Prevention of relapses and disability by interferon beta-1a subcutanously in multiple sclerosis (PRISMS) Study Group;Lancet,1998
3. Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: experience during the first three years;The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group;Neurology,1996
4. The PRISMS-4: long-term efficacy of interferon-ß-1a in relapsing MS;The PRISMS Study Group and the University of British Columbia MS/MRI Analysis Group;Neurology,2001
5. Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis;Petkau;Mult Scler,1997
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis;CNS Drugs;2022-05-19
2. Development of interferon beta-neutralising antibodies in multiple sclerosis—a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2015-08-14
3. Personalized Healthcare in Autoimmune Diseases;Genomic Biomarkers for Pharmaceutical Development;2014
4. Comparison of Site-Specific PEGylations of the N-Terminus of Interferon Beta-1b: Selectivity, Efficiency, and in Vivo/Vitro Activity;Bioconjugate Chemistry;2013-12-20
5. Clinical Effect of Neutralizing Antibodies to Interferon Beta That Persist Long After Cessation of Therapy for Multiple Sclerosis;Archives of Neurology;2010-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3